imagen PET
imagen PET

PET/TC and neurological diseases

PET-CT methodology uses strong magnetic fields and radioactive isotopes with the aim of assessing the brain processes when a person is at rest or performing a specific activity.
This process makes the use of this test fundamental in neurological disorders such as Parkinson’s and Alzheimer’s, as well as in other pathologies.


Early diagnosis of neurological conditions
pet tac neurologia
  • Diagnosis of neurological diseases, such as Parkinson’s and Alzheimer’s.
  • Differential diagnosis and early diagnosis of different dementias.
  • Location of epileptogenic foci in refractory epilepsy prior to surgery.
  • Investigation and assessment of different psychiatric conditions.

Early diagnosis of Alzheimer’s
pet tac pacientes neuro
  • Patients with symptoms of cognitive deterioration can be incorrectly diagnosed with Alzheimer’s disease.
  • Up to one in every five patients diagnosed with Alzheimer’s disease during their lifetime does not have Alzheimer’s disease pathology on post-mortem.
  • Performance of an amyloid-beta PET, enables Alzheimer’s to be diagnosed whensymptoms are still mild, making it possible to establish a plan to try and slow deterioration and improve the patient’s quality of life.
  • It allows doctors to visualise differing cerebral matter with finer volumetric resolution (95 mm3).

Diagnosis and monitoring of Central Nervous System tumours.
  • Differential diagnosis between malignant and benign lesions.
  • Assessment of the degree of malignancy, prognosis and response to treatment, differential diagnosis of recurrence in cerebral tumours treated with radiotherapy and/or radiosurgery.
  • Early diagnosis in a benign tumour which is becoming malignant.


Vídeos Radiología


Tel.: +34 952 908 628

952908898 Oncology
951829978 Diagnosis by imaging
951829947 Gynecology
952908897 Fertility
951829947 Physiotherapy


    Do you want to receive the news of HC Marbella?



    Specialized Care

    Patient care

    HC Professionals

    Subscribe to our newsletter